Information disclosure in Eprosima Dds
CVE-2023-24010
An attacker can arbitrarily craft malicious DDS Participants (or ROS 2 Nodes) with valid certificates to compromise and get full control of the attacked secure DDS databus system by exploiting vulnerable attributes in the configuration of PKCS#7 certificate’s validation. This is caused by a non-compliant implementation of permission document verification used by some DDS vendors. Specifically, an improper use of the OpenSSL PKCS7_verify function used to validate S/MIME signatures.
Vulnerability class: Information Disclosure
EPSS: 0.003 (25.7th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 8.2 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:L.
Affected products
- Eprosima Dds — versions all versions
Weakness classification (CWE)
Public proof-of-concept exploits
References
Frequently asked questions
- What is CVE-2023-24010?
- CVE-2023-24010 is a high-severity vulnerability in Eprosima Dds, classified under Information Disclosure. CVSS score: 8.2/10. Published 2025-01-09.
- How severe is CVE-2023-24010?
- High severity. CVSS v3 base score is 8.2 out of 10.
- Is CVE-2023-24010 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.